Found: 10
Select item for more details and to access through your institution.
Oritavancin Versus Daptomycin for Osteomyelitis Treatment After Surgical Debridement.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 3, p. 535, doi. 10.1007/s40121-024-00925-2
- By:
- Publication type:
- Article
Kimyrsa, An Oritavancin-Containing Product: Clinical Study and Review of Properties.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 5, p. 1, doi. 10.1093/ofid/ofac090
- By:
- Publication type:
- Article
The Practical Problem With Carbapenem Testing and Reporting Accurate Bacterial Susceptibilities.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.841896
- By:
- Publication type:
- Article
Antimicrobial Management of Respiratory Infections in Severe Acute Respiratory Syndrome Coronavirus 2 Patients: Clinical and Antimicrobial Stewardship Programs Conundrums.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 11, p. 1, doi. 10.1093/ofid/ofaa517
- By:
- Publication type:
- Article
Real-World Evidence Studies of Oritavancin Use in Gram-Positive Infections Augment Randomized Controlled Trials to Address Clinical and Economic Outcomes.
- Published in:
- Drugs - Real World Outcomes, 2020, v. 7, p. 2, doi. 10.1007/s40801-020-00189-5
- By:
- Publication type:
- Article
Comparisons of 30-Day Admission and 30-Day Total Healthcare Costs Between Patients Who Were Treated With Oritavancin or Vancomycin for a Skin Infection in the Outpatient Setting.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 12, p. N.PAG, doi. 10.1093/ofid/ofz475
- By:
- Publication type:
- Article
The CHROME Study, a Real-world Experience of Single- and Multiple-Dose Oritavancin for Treatment of Gram-Positive Infections.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 11, p. N.PAG, doi. 10.1093/ofid/ofz479
- By:
- Publication type:
- Article
443. The CHROME Study, a Real-World Experiential Registry of the Use of Oritavancin for Treatment of Gram-Positive Infections.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S219, doi. 10.1093/ofid/ofz360.516
- By:
- Publication type:
- Article
A Real-world Patient Registry for Oritavancin Demonstrates Efficacy and Safety Consistent With the Phase 3 SOLO Program.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 6, p. N.PAG, doi. 10.1093/ofid/ofy051
- By:
- Publication type:
- Article
Stability and Recovery of DIFICID (Fidaxomicin) 200-mg Crushed Tablet Preparations from Three Delivery Vehicles, and Administration of an Aqueous Dispersion via Nasogastric Tube.
- Published in:
- Drugs in R&D, 2014, v. 14, n. 4, p. 309, doi. 10.1007/s40268-014-0067-3
- By:
- Publication type:
- Article